Find Experts

Experts in Oncology
Jairaj K. Acharya Thomas P. Fondy Swarnali Acharyya Bachir Alobeid Richard Baer Aneel K Aggarwal Margaret H Baron Benjamin O. Anderson Parveen Bhatti Marita Zoma Chu Chen Eric Chow Giuseppina Carbone Asma Amleh Katia Basso Govind Bhagat Shiuan Chen Casey L. Daniel WenYong Chen Natalie R. Gassman View More
Ming Tan

Associate Professor
Oncologic Sciences
Mitchell Cancer Institute
United States of America

Professor Oncology
Biography

Dr. Ming Tan has been Associate Professor of Oncologic Sciences and Vincent F. Kilborn, Jr. Cancer Research Scholar at MCI since 2007. His laboratory focuses on the molecular mechanisms of tumor progression, metastasis, and therapeutic resistance of human breast cancer, melanoma, and other cancer types. The ultimate goal of Dr. Tan’s research is to translate the knowledge acquired in the laboratory into future novel therapeutics. Prior to joining the staff at MCI, Dr. Tan served as Assistant Professor (Research) with the University of Texas MD Anderson Cancer Center. He received his Ph.D. from the University of Texas MD Anderson Cancer Center and Health Science Center and his M.D. from West China University of Medical Sciences Chengdu, China. Dr. Tan is the author of numerous articles in scientific and medical journals. 

Research Intrest

Metabolism and cancer, Cell death and stress responsive signaling, MicroRNA and cancer, Cancer stem cell, Cancer metastasis, 

List of Publications
Samulski RJ, Berns KI, Tan M, Muzyczka N. Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proceedings of the National Academy of Sciences. 1982 Mar 1;79(6):2077-81.
Zhao Y, Butler EB, Tan M. Targeting cellular metabolism to improve cancer therapeutics. Cell death & disease. 2013 Mar;4(3):e532.
Zhang P, Cheng H, Edwards RL, Chen F, Wang Y, Yang X, Liu J, Tan M, Wang X, Liu J, An C. A test of climate, sun, and culture relationships from an 1810-year Chinese cave record. science. 2008 Nov 7;322(5903):940-2.
Nagata Y, Lan KH, Zhou X, Tan M, Esteva FJ, Sahin AA, Klos KS, Li P, Monia BP, Nguyen NT, Hortobagyi GN. PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients. Cancer cell. 2004 Aug 31;6(2):117-27.
Experts in United States of America
Jairaj K. Acharya John Belote Wayde Brown Aimée M. Dudley Jon P Mochel Rabaa M. Al-Rousan Chancellor, Renate Karen Lee Abt Lin Li Hui-Hsien Chou Hamed I. Aly Cory K. Adams Mark Ehrensberger Jose Buitrago Gerhard J. Barone Jacquelyne Adams Jon Calabria Shelley Cannady Susan B. Adams Stoica George Daniel E. Acuna Tal Amasay Jason R. Wiles Matthew H Andersen Brian Rothman View More